Bright Minds Biosciences, Inc. (DRUG.CX)
73.26
+2.37
(+3.34%)
CAD |
CNSX |
Oct 23, 16:00
Bright Minds Biosciences Net Income (Quarterly) : -2.398M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.398M |
| March 31, 2026 | -10.46M |
| December 31, 2025 | -7.565M |
| September 30, 2025 | -4.086M |
| June 30, 2025 | -5.243M |
| March 31, 2025 | -2.950M |
| December 31, 2024 | 0.0496M |
| September 30, 2024 | -0.7734M |
| June 30, 2024 | 0.2299M |
| March 31, 2024 | -0.5741M |
| December 31, 2023 | -1.684M |
| September 30, 2023 | -1.528M |
| June 30, 2023 | -1.458M |
| Date | Value |
|---|---|
| March 31, 2023 | -2.050M |
| December 31, 2022 | -2.335M |
| September 30, 2022 | -2.961M |
| June 30, 2022 | -2.658M |
| March 31, 2022 | -4.488M |
| December 31, 2021 | -4.858M |
| September 30, 2021 | -2.867M |
| June 30, 2021 | -3.534M |
| March 31, 2021 | -1.583M |
| December 31, 2020 | -0.7534M |
| March 31, 2020 | |
| December 31, 2019 | -0.0314M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Fennec Pharmaceuticals, Inc. | 2.731M |
| Microbix Biosystems, Inc. | -0.8068M |
| Helix BioPharma Corp. | -0.671M |
| Sernova Biotherapeutics, Inc. | -2.529M |
| Hemostemix, Inc. | -0.6324M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.398M |
| EPS Diluted (Quarterly) | -0.244 |
| Enterprise Value | 414.88M |
| Earnings Yield | -3.93% |
| Normalized Earnings Yield | -3.930 |